Allergan is recalling approximately 163,694 cartons of INFeD (iron dextran injection USP) 100 mg elemental iron/2 ml because stability testing showed the iron content did not meet required specifications. This prescription medication is used to treat iron deficiency and was distributed nationwide in single-dose vials and 10-vial cartons. Consumers who have these products should be aware that the medication may not provide the intended therapeutic effect due to the stability failure.
The product failed stability testing for iron content, meaning the concentration of iron in the injection may be inconsistent with the labeled amount. This could lead to patients receiving an incorrect dose, potentially resulting in ineffective treatment for iron deficiency anemia.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.